fate therapeutics stock price target

Wedbush Adjusts Fate Therapeutics Price Target to 77 From 74 Keeps Outperform Ratin. Over the past 96 months FATEs pricesales ratio has gone.

Could Fate Therapeutics Be A Millionaire Maker Stock The Motley Fool

Is 1761 for 2026 Mar.

. Learn more on FATEs analyst rating history. Over the past 96 months FATEs priceearnings ratio has gone down 256. 7 2020 at 718 am.

Is 13835 for 2027 Mar. Price Price Target Lowest. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.

Is 15507 and for 2032 Mar. The average twelve-month price target for Fate Therapeutics is 8722 with a high price target of 11600 and a low price target of 6000. Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of.

9 equities research analysts have issued 1 year price targets for Fate Therapeutics stock. 5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 9360 with the highest FATE stock price forecast at 11500 and the lowest FATE stock price forecast at 7400. 69 rows FATE Stock Trend.

Find the latest Fate Therapeutics Inc. Ad Walk into the Future Confidently. In comparison to the median Healthcare stock FATEs pricesales ratio is 11793 higher now standing at 1452.

Find the latest Fate Therapeutics Inc. ET by Tomi Kilgore Fate Therapeutics stock price target raised to 65 from 40 at Truist. AFTER HOURS 543 PM EDT 041222.

According to the issued ratings of 9 analysts in the last year the consensus rating for Fate Therapeutics stock is Buy based on the current 2 hold ratings and 7 buy ratings for FATE. Wall Street is positive on Fate Therapeutics Inc FATE. On average analysts give the stock a Strong Buy rating.

Discover Which Investments Align with Your Financial Goals. The average price target is 9300 with a high forecast of 14500 and a low forecast of 6000. FATE has a greater upside potential average analyst target price relative to current price than 149379 of stocks in the mid market cap category.

Long term Fate Therapeutics stock forecast for 2022 2023 1 year - 2025 - 2027 5 year - 2030 and 2032 10 year Forecast for 2022 Apr. FATE stock quote history news and other vital information to help you with your stock trading and investing. This suggests a possible upside of 2054 from the stocks current price.

This chart shows the closing price for FATE for the last year in relation to the current analyst high average and low pricetarget. Their forecasts range from 6000 to 11600. HC Wainwright Adjusts Fate Therapeutics Price Target to 115 from 122 Keeps Buy Rati.

On average they anticipate Fate Therapeutics stock price to reach 8722 in the next twelve months. That average ranking earns the stock an Analyst Rating of 63 which is better than 63 of stocks based on data compiled by. The average price target is 103866 which means analysts expect the stock to rise by 6930 over the next twelve months.

The average price target represents a 16855 upside from the last price of 3463. Fate Therapeutics stock price target raised to 88 from 55 at Wedbush Dec. Find a Dedicated Financial Advisor Now.

Stock Price Forecast The 18 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 9900 with a high estimate of 13500 and a low estimate of 4200. The company has an average price target. In the last 3 months 4 analysts have offered 12-month price targets for Fate Therapeutics.

The average price target is 000 with a high estimate of 000 and a low estimate of 000. 13000 The average price target includes all analyst analysis not just the most recent analysis presented in the chart. The stock is moving within a very wide and.

FATE analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. Sign in to your SmartPortfolio to see more analyst recommendations. Is 3589 for 2023 Mar.

Fate Therapeutics reported interim results from 14 patients treated with FT596 an off-the-shelf immunotherapy made of natural killer cells engineered to target CD19. Is 13930 for 2031 Mar. Nasdaq AT CLOSE 400 PM EDT 041222.

Ad 1000 Strong Buy Stocks that Double the SP. Forecast target price for 05-03-2022. Chart FATE THERAPEUTICS INC.

Fate Therapeutics Stock Forecast 05-03-2022. In terms of how Fate Therapeutics Inc fares relative to Pharmaceutical Products stocks note that its average analyst price target is higher than 145991 of that group.

Akebia Is There Any Value Left After The Crl Analyst Weighs In